HEADER HORMONE/GROWTH FACTOR 28-JUN-06 2HHO TITLE NMR STRUCTURE OF HUMAN INSULIN MUTANT GLY-B8-SER, HIS-B10-ASP PRO-B28- TITLE 2 LYS, LYS-B29-PRO, 20 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN A CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: INSULIN B CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: INS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: INS; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HORMONE, HUMAN INSULIN, MUTANT, HORMONE-GROWTH FACTOR COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Q.X.HUA,S.NAKAGAWA,S.Q.HU,W.JIA,M.A.WEISS REVDAT 4 20-OCT-21 2HHO 1 REMARK SEQADV REVDAT 3 24-FEB-09 2HHO 1 VERSN REVDAT 2 05-SEP-06 2HHO 1 JRNL REVDAT 1 18-JUL-06 2HHO 0 JRNL AUTH Q.X.HUA,S.NAKAGAWA,S.Q.HU,W.JIA,S.WANG,M.A.WEISS JRNL TITL TOWARD THE ACTIVE CONFORMATION OF INSULIN: STEREOSPECIFIC JRNL TITL 2 MODULATION OF A STRUCTURAL SWITCH IN THE B CHAIN. JRNL REF J.BIOL.CHEM. V. 281 24900 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16762918 JRNL DOI 10.1074/JBC.M602691200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.85, CNS 1.1 REMARK 3 AUTHORS : BRUNGER (X-PLOR), BRUNGER (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RMSD VALUES FOR ALL 20 STRUCTURES REMARK 3 VERSUS GEOMETRIC AVERAGE: (BACKBONE, A2-A20, B4-B24) 0.60 REMARK 3 ANGSTROM REMARK 4 REMARK 4 2HHO COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038357. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY; NOESY; COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 700 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.5 REMARK 210 METHOD USED : DISTANCE GEOMETRY AND SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 40 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR NMR TECHNIQUES. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ALA B 14 H LEU B 17 1.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 4 -31.68 -35.32 REMARK 500 1 THR A 8 38.41 -88.58 REMARK 500 1 SER A 9 -151.71 172.55 REMARK 500 1 CYS A 11 -151.69 -119.14 REMARK 500 1 CYS A 20 150.00 -43.24 REMARK 500 1 CYS B 7 87.18 -53.94 REMARK 500 1 SER B 8 -153.73 173.13 REMARK 500 1 ALA B 14 -73.19 -47.34 REMARK 500 1 CYS B 19 56.36 -110.93 REMARK 500 1 TYR B 26 44.70 -84.61 REMARK 500 1 THR B 27 -167.53 -77.92 REMARK 500 2 ILE A 2 -39.80 -158.71 REMARK 500 2 GLU A 4 -35.58 -36.27 REMARK 500 2 THR A 8 46.74 -106.41 REMARK 500 2 SER A 9 -162.19 169.70 REMARK 500 2 CYS A 11 -172.72 60.95 REMARK 500 2 GLN B 4 68.65 -159.98 REMARK 500 2 HIS B 5 -167.01 47.29 REMARK 500 2 LEU B 6 -157.50 -138.73 REMARK 500 2 CYS B 7 36.21 84.86 REMARK 500 2 SER B 8 -154.62 -150.90 REMARK 500 2 CYS B 19 -74.67 -80.30 REMARK 500 2 THR B 27 -96.22 -65.65 REMARK 500 2 LYS B 28 105.54 -45.22 REMARK 500 3 GLU A 4 -26.68 -39.87 REMARK 500 3 SER A 9 -153.65 -158.10 REMARK 500 3 CYS A 11 -156.21 -93.67 REMARK 500 3 GLN B 4 27.07 -157.29 REMARK 500 3 HIS B 5 -167.58 60.21 REMARK 500 3 LEU B 6 -156.62 -114.43 REMARK 500 3 ALA B 14 -72.49 -45.68 REMARK 500 3 LEU B 17 -70.92 -91.42 REMARK 500 3 CYS B 19 -74.45 -76.65 REMARK 500 3 TYR B 26 48.33 -82.09 REMARK 500 3 THR B 27 -103.09 -86.90 REMARK 500 4 GLN A 5 -70.86 -41.97 REMARK 500 4 THR A 8 52.94 -118.80 REMARK 500 4 SER A 9 -171.92 164.22 REMARK 500 4 CYS A 20 155.99 -49.87 REMARK 500 4 HIS B 5 -165.99 58.58 REMARK 500 4 LEU B 6 -157.05 -130.64 REMARK 500 4 CYS B 7 58.27 72.34 REMARK 500 4 SER B 8 -167.79 -165.76 REMARK 500 4 ALA B 14 -72.85 -46.98 REMARK 500 4 LEU B 17 -69.93 -91.10 REMARK 500 5 GLN A 5 -70.25 -57.31 REMARK 500 5 SER A 9 -134.19 68.18 REMARK 500 5 CYS A 11 -146.66 -144.44 REMARK 500 5 CYS A 20 175.31 -47.49 REMARK 500 5 HIS B 5 -167.58 44.53 REMARK 500 REMARK 500 THIS ENTRY HAS 240 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 1 ARG B 22 0.24 SIDE CHAIN REMARK 500 2 ARG B 22 0.26 SIDE CHAIN REMARK 500 3 ARG B 22 0.23 SIDE CHAIN REMARK 500 4 ARG B 22 0.25 SIDE CHAIN REMARK 500 5 ARG B 22 0.32 SIDE CHAIN REMARK 500 7 ARG B 22 0.32 SIDE CHAIN REMARK 500 8 ARG B 22 0.30 SIDE CHAIN REMARK 500 9 ARG B 22 0.25 SIDE CHAIN REMARK 500 10 ARG B 22 0.23 SIDE CHAIN REMARK 500 11 ARG B 22 0.18 SIDE CHAIN REMARK 500 12 ARG B 22 0.30 SIDE CHAIN REMARK 500 13 ARG B 22 0.18 SIDE CHAIN REMARK 500 14 ARG B 22 0.28 SIDE CHAIN REMARK 500 15 ARG B 22 0.20 SIDE CHAIN REMARK 500 16 ARG B 22 0.13 SIDE CHAIN REMARK 500 17 ARG B 22 0.27 SIDE CHAIN REMARK 500 18 ARG B 22 0.23 SIDE CHAIN REMARK 500 19 ARG B 22 0.32 SIDE CHAIN REMARK 500 20 ARG B 22 0.31 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 2HHO A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 2HHO B 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 2HHO SER B 8 UNP P01308 GLY 32 ENGINEERED MUTATION SEQADV 2HHO ASP B 10 UNP P01308 HIS 34 ENGINEERED MUTATION SEQADV 2HHO LYS B 28 UNP P01308 PRO 52 ENGINEERED MUTATION SEQADV 2HHO PRO B 29 UNP P01308 LYS 53 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS THR SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS SER SER ASP LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR LYS PRO THR HELIX 1 1 VAL A 3 THR A 8 1 6 HELIX 2 2 SER A 12 GLU A 17 1 6 HELIX 3 3 SER B 8 CYS B 19 1 12 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.02 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.02 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL ENDMDL MASTER 181 0 0 3 0 0 0 6 0 0 0 5 END